DNA Methylation & Demethylase Activity Assays Service
Inquiry
DNA methyltransferases and demethylases dynamically control cytosine methylation states, making accurate assessment of their enzymatic activity essential for epigenetic mechanism studies and therapeutic target discovery. CD BioSciences provides sensitive and customizable DNA methylation and demethylase activity assay services to quantitatively evaluate enzyme function under well-defined in vitro conditions.
The Mechanism and Dynamic Regulation of DNA Methylation
DNA methylation is a fundamental epigenetic mark involving the addition of a methyl group to cytosine residues, primarily at CpG dinucleotides, catalyzed by DNA methyltransferases (DNMTs). This creates 5-methylcytosine (5-mC), which is crucial for regulating gene expression and maintaining genomic stability. The methylation landscape is dynamically regulated by the opposing activities of DNMTs and demethylases. Active demethylation is initiated by TET dioxygenases, which oxidize 5-mC to 5-hydroxymethylcytosine (5hmC) and further derivatives. These oxidized bases can be excised via the Base Excision Repair (BER) pathway, ultimately restoring an unmethylated cytosine. This cycle allows for precise, rapid epigenetic reprogramming essential for development and cellular differentiation.
Fig.1 Schematic representation of DNA methylation patterning. (Parveen N, et al., 2021)
Significance of DNA Methylation & Demethylase Activity Assays
Quantifying the activity of DNA methylation and demethylase enzymes is critical for both basic and translational research. Since aberrant activity of these enzymes is a direct driver of dysfunctional methylation patterns in diseases like cancer and neurological disorders, their assay provides direct functional insights into disease mechanisms. These assays are indispensable for epigenetic drug discovery, enabling the screening and mechanistic evaluation of inhibitors targeting DNMTs or TET proteins. Furthermore, they are vital tools for studying normal biological processes, including stem cell differentiation, development, and cellular responses to environmental stimuli, offering a dynamic view of the functional epigenome beyond static methylation snapshots.
Our Services
CD BioSciences provides a comprehensive suite of specialized DNA methylation and demethylase activity assay services designed to characterize the enzymatic drivers of epigenetic dynamics. Our platform delivers accurate, quantitative profiling of DNA methyltransferases (DNMTs) and demethylases (including TET proteins and BER glycosylases), empowering researchers to investigate fundamental epigenetic mechanisms in development, disease pathogenesis, and the discovery of novel therapeutic interventions.
Core Assay Items
This service provides quantitative analysis of DNMT enzymatic activity, which is crucial for establishing and maintaining CpG methylation patterns essential for gene silencing, genomic imprinting, and X-chromosome inactivation. Utilizing robust, plate-based assays with radiolabeled AdoMet or versatile colorimetric/fluorometric methods, we deliver precise kinetic data (Vmax, Km) to support epigenetic drug screening, mechanistic studies of transcriptional regulation, and research into developmental and cancer biology.
Our assay quantitatively measures the activity of Ten-Eleven Translocation (TET) dioxygenases, the key enzymes responsible for active DNA demethylation through the iterative oxidation of 5-methylcytosine. By detecting the production of 5-carboxylcytosine or other oxidative intermediates, this service enables critical research into dynamic epigenetic reprogramming, stem cell pluripotency, and the role of TET dysfunction in various cancers and neurological disorders.
This service analyzes the activity of specific BER glycosylases (e.g., TDG, SMUG1) that initiate the removal of oxidized or deaminated bases, a process linked to both DNA repair and active demethylation pathways. We measure the enzyme's ability to excise modified bases from defined oligonucleotide substrates, providing vital insights into mechanisms maintaining genomic stability, epigenetic integrity, and their implications in aging, neurodegeneration, and cancer.
Service Applications
Enzyme Kinetic Characterization
- Determination of Michaelis-Menten kinetics (Km, Vmax) for DNMTs and demethylases using varying concentrations of DNA substrate, SAM, or co-factors (e.g., α-KG for TETs).
- Comprehensive inhibitor potency profiling, including IC50 determination, mechanism of action studies (competitive, non-competitive, uncompetitive), and calculation of inhibition constants (Ki).
- Substrate specificity mapping across different DNA sequences, contexts (CpG vs. non-CpG), and methylation states (e.g., hemi- vs. fully-methylated DNA for DNMT1).
Biological Sample Analysis
- Profiling of endogenous DNMT or TET enzyme activities directly from cell lysates or tissue homogenates, revealing disease- or state-specific enzymatic alterations.
- Analysis of tissue-specific methylation dynamics in animal models of disease, offering functional insights complementary to bisulfite sequencing.
- Monitoring epigenetic changes during stem cell differentiation or cellular reprogramming by tracking the activity shifts of key methylation and demethylation enzymes.
Drug Discovery & Development Support
- High-throughput screening (HTS) of large epigenetic compound libraries against target enzymes (e.g., DNMT1, TET2) in 384-well plate formats.
- Detailed mechanism of action (MOA) studies for known (e.g., 5-azacytidine, decitabine) and novel DNMT inhibitors.
- Selectivity profiling of lead compounds against related enzyme families and isoforms to minimize off-target effects and ensure drug specificity.
Service Technologies
Radioisotopic Methyltransferase Assays
Utilizing 3H-labeled S-adenosylmethionine (SAM) as the methyl donor, we measure DNMT activity through direct quantification of radiolabeled DNA products. This gold-standard method offers:
- Sensitive detection of low-abundance DNMT activities
- Linear dynamic range over three orders of magnitude
- Direct correlation with enzymatic turnover rates
Fluorescence-Based Detection Systems
Our fluorescence polarization and TR-FRET platforms enable homogeneous, high-throughput screening capabilities:
- Real-time kinetic monitoring of methylation dynamics
- 384-well format compatibility for compound screening
- Minimal sample manipulation reducing experimental variability
Mass Spectrometry-Based Quantification
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) provides absolute quantification of:
- 5-methylcytosine (5mC) and its oxidation products (5hmC, 5fC, 5caC)
- Site-specific methylation levels with base resolution
- Simultaneous detection of multiple modifications in complex samples
Service Workflow
Initial Project Consultation
Customized Assay Design
Sample Preparation & QC
Assay Execution & Acquisition
Data Analysis & Reporting
Results Review & Support
Deliverables
Upon project completion, you will receive a comprehensive data package, including:
- Comprehensive Experimental Protocol & Data Report
- Complete Raw & Analyzed Datasets
- Publication-Ready Figures & Graphs
- Detailed Enzymatic Kinetic Analysis (Km, Vmax)
- Result Interpretation & Summary Memo
- Project Consultation & Support
We adhere to stringent internal quality control (QC) protocols. Every assay run includes a full set of controls. Enzyme kinetic data is fitted using non-linear regression analysis (e.g., Michaelis-Menten, Hill equation) in specialized software (e.g., GraphPad Prism). Inhibition data is fitted to a four-parameter logistic model to determine IC50. All statistical analyses (standard deviation, standard error) are clearly reported.
Our Advantages
- Integrated Technology Platform. We offer the full spectrum from high-throughput fluorescence screening to definitive isotopic and mass spec validation, allowing us to recommend and execute the optimal assay for your specific need, budget, and sample type.
- Tailored & Flexible Design. Beyond standard assays, we excel at developing custom protocols. We can utilize client-provided unique DNA substrates (specific sequences, hairpins, pre-modified oligos) or enzyme variants (mutants, tagged proteins) to answer precise mechanistic questions.
- End-to-End Expert Partnership. Your project is assigned a dedicated scientist who provides consultation from experimental design through data interpretation. We ensure the assay is correctly configured to answer your biological question and help you derive meaningful conclusions from the results.
- Rigorous Data Quality. Every experiment includes full sets of positive controls (enzyme of known activity) and negative controls (no enzyme, heat-inactivated samples). All reported values (Km, Vmax, IC50) are derived from non-linear regression fits of replicate data points, ensuring statistical robustness and reproducibility.
Frequently Asked Questions (FAQs)
Q1: What type of samples can you analyze?
A: We accept purified recombinant enzymes, immunoprecipitated proteins, nuclear extracts, and cell/tissue lysates. Please contact us for specific requirements on sample amount, concentration, and buffer compatibility.
Q2: Can I use my own custom DNA sequence as a substrate?
A: Absolutely. We strongly encourage clients to provide sequences relevant to their research. We will synthesize, purify, and quality-control the oligonucleotides for the assay.
Q3: What deliverables do you provide for inhibitor screening?
A: We provide dose-response curves, calculated IC50 values, and can perform follow-up experiments to determine the mode of inhibition (competitive, non-competitive, etc.) and inhibition constant (Ki).
Q4: How do I choose between fluorescence, radiometric, and MS methods?
A: Fluorescence is best for high-throughput screening. Radiometric offers utmost sensitivity for low-activity samples. MS provides absolute quantification and multiplexing of modifications. We will guide you based on your goals.
Q5: What is your typical turnaround time?
A: For standard assays, initial data is typically provided within 2-3 weeks of sample receipt. Complex or custom projects may require additional time, which will be discussed during project consultation.
CD BioSciences provides accurate, reproducible, and insightful DNA methylation and demethylase activity assays to support the full spectrum of epigenetic research, from foundational mechanism studies to translational drug discovery. Our strength lies in combining deep biochemical expertise with a flexible, multi-technology platform, allowing us to tailor the optimal assay strategy for your unique biological questions and sample types. Contact us to discuss your project goals and receive a customized assay strategy tailored to your research needs.
Reference
1. Parveen N, Dhawan S. DNA methylation patterning and the regulation of beta cell homeostasis[J]. Frontiers in endocrinology, 2021, 12: 651258.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
